Annual Operating Profit
-$20.49 M
+$33.74 M+62.21%
31 December 2023
Summary:
Rigel Pharmaceuticals annual operaing income is currently -$20.49 million, with the most recent change of +$33.74 million (+62.21%) on 31 December 2023. During the last 3 years, it has risen by +$8.48 million (+29.28%). RIGL annual operating profit is now -158.02% below its all-time high of $35.32 million, reached on 31 December 2010.RIGL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$14.06 M
+$13.61 M+3044.52%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly operating income is currently $14.06 million, with the most recent change of +$13.61 million (+3044.52%) on 30 September 2024. Over the past year, it has increased by +$18.52 million (+414.80%). RIGL quarterly operating profit is now -72.09% below its all-time high of $50.36 million, reached on 30 September 2010.RIGL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$9.50 M
+$18.52 M+205.38%
30 September 2024
Summary:
Rigel Pharmaceuticals TTM operating income is currently $9.50 million, with the most recent change of +$18.52 million (+205.38%) on 30 September 2024. Over the past year, it has increased by +$28.56 million (+149.86%). RIGL TTM operating profit is now -74.18% below its all-time high of $36.81 million, reached on 31 March 2011.RIGL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.2% | +414.8% | +149.9% |
| 3 y3 years | +29.3% | +171.0% | +195.9% |
| 5 y5 years | +71.8% | +216.8% | +119.3% |
RIGL Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -128.3% | +62.2% | at high | +153.5% | at high | +112.3% |
| 5 y | 5 years | -128.3% | +71.8% | -66.3% | +153.5% | at high | +112.3% |
| alltime | all time | -158.0% | +85.0% | -72.1% | +136.3% | -74.2% | +106.9% |
Rigel Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.06 M(+3044.5%) | $9.50 M(-205.4%) |
| June 2024 | - | $447.00 K(-106.4%) | -$9.02 M(-38.8%) |
| Mar 2024 | - | -$6.97 M(-454.3%) | -$14.73 M(-28.1%) |
| Dec 2023 | -$20.49 M(-62.2%) | $1.97 M(-144.0%) | -$20.49 M(+7.5%) |
| Sept 2023 | - | -$4.46 M(-15.2%) | -$19.06 M(-42.2%) |
| June 2023 | - | -$5.27 M(-58.6%) | -$33.00 M(-18.9%) |
| Mar 2023 | - | -$12.72 M(-474.4%) | -$40.69 M(-25.0%) |
| Dec 2022 | -$54.23 M(+504.2%) | $3.40 M(-118.5%) | -$54.23 M(-28.2%) |
| Sept 2022 | - | -$18.40 M(+41.9%) | -$75.53 M(-1.8%) |
| June 2022 | - | -$12.96 M(-50.6%) | -$76.91 M(-0.1%) |
| Mar 2022 | - | -$26.26 M(+46.7%) | -$76.99 M(+757.8%) |
| Dec 2021 | -$8.97 M(-69.0%) | -$17.90 M(-9.5%) | -$8.97 M(-9.4%) |
| Sept 2021 | - | -$19.79 M(+51.6%) | -$9.90 M(+153.9%) |
| June 2021 | - | -$13.05 M(-131.2%) | -$3.90 M(-52.7%) |
| Mar 2021 | - | $41.76 M(-321.8%) | -$8.24 M(-71.5%) |
| Dec 2020 | -$28.97 M(-58.1%) | -$18.83 M(+36.6%) | -$28.97 M(+5.4%) |
| Sept 2020 | - | -$13.78 M(-20.8%) | -$27.48 M(+6.8%) |
| June 2020 | - | -$17.39 M(-182.7%) | -$25.74 M(-13.3%) |
| Mar 2020 | - | $21.03 M(-221.3%) | -$29.69 M(-57.0%) |
| Dec 2019 | -$69.09 M(-4.9%) | -$17.34 M(+44.0%) | -$69.09 M(+40.4%) |
| Sept 2019 | - | -$12.04 M(-43.6%) | -$49.22 M(-20.0%) |
| June 2019 | - | -$21.34 M(+16.1%) | -$61.55 M(-7.2%) |
| Mar 2019 | - | -$18.38 M(-825.8%) | -$66.33 M(-8.7%) |
| Dec 2018 | -$72.68 M(-8.7%) | $2.53 M(-110.4%) | -$72.68 M(-28.3%) |
| Sept 2018 | - | -$24.37 M(-6.7%) | -$101.43 M(+6.9%) |
| June 2018 | - | -$26.11 M(+5.6%) | -$94.92 M(+7.7%) |
| Mar 2018 | - | -$24.73 M(-5.6%) | -$88.15 M(+10.7%) |
| Dec 2017 | -$79.62 M(+24.5%) | -$26.21 M(+46.8%) | -$79.62 M(+15.1%) |
| Sept 2017 | - | -$17.86 M(-7.7%) | -$69.19 M(+1.3%) |
| June 2017 | - | -$19.34 M(+19.4%) | -$68.30 M(+9.1%) |
| Mar 2017 | - | -$16.20 M(+2.6%) | -$62.61 M(-2.1%) |
| Dec 2016 | -$63.97 M(+23.6%) | -$15.79 M(-7.0%) | -$63.97 M(+5.0%) |
| Sept 2016 | - | -$16.97 M(+24.3%) | -$60.93 M(+20.1%) |
| June 2016 | - | -$13.65 M(-22.3%) | -$50.74 M(-0.6%) |
| Mar 2016 | - | -$17.57 M(+37.8%) | -$51.07 M(-1.3%) |
| Dec 2015 | -$51.74 M(-43.3%) | -$12.75 M(+88.0%) | -$51.74 M(-15.7%) |
| Sept 2015 | - | -$6.78 M(-51.5%) | -$61.36 M(-18.9%) |
| June 2015 | - | -$13.97 M(-23.4%) | -$75.62 M(-13.2%) |
| Mar 2015 | - | -$18.24 M(-18.5%) | -$87.11 M(-4.5%) |
| Dec 2014 | -$91.25 M(+3.9%) | -$22.37 M(+6.3%) | -$91.25 M(+6.3%) |
| Sept 2014 | - | -$21.04 M(-17.3%) | -$85.83 M(-1.4%) |
| June 2014 | - | -$25.46 M(+13.7%) | -$87.04 M(+3.0%) |
| Mar 2014 | - | -$22.39 M(+32.1%) | -$84.47 M(-3.8%) |
| Dec 2013 | -$87.79 M(-11.7%) | -$16.94 M(-23.9%) | -$87.79 M(-9.0%) |
| Sept 2013 | - | -$22.25 M(-2.8%) | -$96.46 M(-3.3%) |
| June 2013 | - | -$22.89 M(-11.0%) | -$99.78 M(-2.0%) |
| Mar 2013 | - | -$25.71 M(+0.4%) | -$101.78 M(+2.4%) |
| Dec 2012 | -$99.38 M | -$25.62 M(+0.2%) | -$99.38 M(-0.3%) |
| Sept 2012 | - | -$25.57 M(+2.8%) | -$99.67 M(+8.2%) |
| June 2012 | - | -$24.88 M(+6.7%) | -$92.14 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$23.31 M(-10.0%) | -$88.82 M(+2.8%) |
| Dec 2011 | -$86.37 M(-344.6%) | -$25.91 M(+43.6%) | -$86.37 M(+7.8%) |
| Sept 2011 | - | -$18.04 M(-16.3%) | -$80.13 M(+583.2%) |
| June 2011 | - | -$21.56 M(+3.3%) | -$11.73 M(-131.9%) |
| Mar 2011 | - | -$20.86 M(+6.1%) | $36.81 M(+4.2%) |
| Dec 2010 | $35.32 M(-131.8%) | -$19.67 M(-139.1%) | $35.32 M(+18.2%) |
| Sept 2010 | - | $50.36 M(+86.7%) | $29.88 M(-163.4%) |
| June 2010 | - | $26.98 M(-220.7%) | -$47.13 M(-54.7%) |
| Mar 2010 | - | -$22.35 M(-11.0%) | -$104.11 M(-6.1%) |
| Dec 2009 | -$110.90 M(-18.9%) | -$25.10 M(-5.8%) | -$110.90 M(-7.4%) |
| Sept 2009 | - | -$26.66 M(-11.1%) | -$119.80 M(-9.1%) |
| June 2009 | - | -$30.00 M(+2.9%) | -$131.83 M(-3.9%) |
| Mar 2009 | - | -$29.14 M(-14.3%) | -$137.11 M(+0.3%) |
| Dec 2008 | -$136.71 M(+71.9%) | -$34.01 M(-12.1%) | -$136.71 M(+11.2%) |
| Sept 2008 | - | -$38.68 M(+9.7%) | -$122.96 M(+17.4%) |
| June 2008 | - | -$35.28 M(+22.7%) | -$104.70 M(+16.3%) |
| Mar 2008 | - | -$28.75 M(+41.9%) | -$90.03 M(+13.2%) |
| Dec 2007 | -$79.53 M(+84.7%) | -$20.26 M(-0.8%) | -$79.53 M(+4.4%) |
| Sept 2007 | - | -$20.43 M(-0.9%) | -$76.16 M(+11.2%) |
| June 2007 | - | -$20.61 M(+13.0%) | -$68.47 M(+33.0%) |
| Mar 2007 | - | -$18.24 M(+8.0%) | -$51.47 M(+19.6%) |
| Dec 2006 | -$43.05 M(-10.2%) | -$16.89 M(+32.7%) | -$43.05 M(+18.8%) |
| Sept 2006 | - | -$12.73 M(+252.6%) | -$36.24 M(-2.8%) |
| June 2006 | - | -$3.61 M(-63.2%) | -$37.29 M(-19.5%) |
| Mar 2006 | - | -$9.82 M(-2.7%) | -$46.31 M(-3.4%) |
| Dec 2005 | -$47.92 M(-15.7%) | -$10.09 M(-26.8%) | -$47.92 M(-9.1%) |
| Sept 2005 | - | -$13.78 M(+9.1%) | -$52.74 M(-4.6%) |
| June 2005 | - | -$12.63 M(+10.5%) | -$55.28 M(+0.2%) |
| Mar 2005 | - | -$11.43 M(-23.3%) | -$55.18 M(-3.0%) |
| Dec 2004 | -$56.87 M(+39.3%) | -$14.90 M(-8.7%) | -$56.87 M(+5.6%) |
| Sept 2004 | - | -$16.32 M(+30.3%) | -$53.84 M(+10.9%) |
| June 2004 | - | -$12.53 M(-4.5%) | -$48.57 M(+4.7%) |
| Mar 2004 | - | -$13.12 M(+10.5%) | -$46.40 M(+13.7%) |
| Dec 2003 | -$40.83 M(+10.3%) | -$11.87 M(+7.5%) | -$40.83 M(+10.5%) |
| Sept 2003 | - | -$11.05 M(+6.6%) | -$36.94 M(+2.6%) |
| June 2003 | - | -$10.36 M(+37.3%) | -$36.00 M(-0.4%) |
| Mar 2003 | - | -$7.55 M(-5.5%) | -$36.13 M(-2.4%) |
| Dec 2002 | -$37.02 M(+48.3%) | -$7.99 M(-20.9%) | -$37.02 M(+5.1%) |
| Sept 2002 | - | -$10.10 M(-3.7%) | -$35.23 M(+11.7%) |
| June 2002 | - | -$10.49 M(+24.3%) | -$31.55 M(+10.1%) |
| Mar 2002 | - | -$8.44 M(+36.0%) | -$28.65 M(+14.8%) |
| Dec 2001 | -$24.96 M(-2.1%) | -$6.20 M(-3.3%) | -$24.96 M(-54.0%) |
| Sept 2001 | - | -$6.42 M(-15.5%) | -$54.27 M(+21.9%) |
| June 2001 | - | -$7.60 M(+60.1%) | -$44.52 M(+32.6%) |
| Mar 2001 | - | -$4.74 M(-86.6%) | -$33.59 M(+31.7%) |
| Dec 2000 | -$25.50 M(+111.1%) | -$35.51 M(-1164.5%) | -$25.50 M(-354.8%) |
| Sept 2000 | - | $3.34 M(0.0%) | $10.01 M(+50.0%) |
| June 2000 | - | $3.34 M(0.0%) | $6.67 M(+100.0%) |
| Mar 2000 | - | $3.34 M | $3.34 M |
| Dec 1999 | -$12.08 M | - | - |
FAQ
- What is Rigel Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual operating profit year-on-year change?
- What is Rigel Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly operating profit year-on-year change?
- What is Rigel Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals TTM operating profit year-on-year change?
What is Rigel Pharmaceuticals annual operaing income?
The current annual operating profit of RIGL is -$20.49 M
What is the all time high annual operating profit for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual operaing income is $35.32 M
What is Rigel Pharmaceuticals annual operating profit year-on-year change?
Over the past year, RIGL annual operaing income has changed by +$33.74 M (+62.21%)
What is Rigel Pharmaceuticals quarterly operating income?
The current quarterly operating profit of RIGL is $14.06 M
What is the all time high quarterly operating profit for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly operating income is $50.36 M
What is Rigel Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, RIGL quarterly operating income has changed by +$18.52 M (+414.80%)
What is Rigel Pharmaceuticals TTM operating income?
The current TTM operating profit of RIGL is $9.50 M
What is the all time high TTM operating profit for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high TTM operating income is $36.81 M
What is Rigel Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, RIGL TTM operating income has changed by +$28.56 M (+149.86%)